Home › Phenylketonuria › Indiana
Phenylketonuria clinical trials in Indiana
6 studies for Phenylketonuria are looking for participants at sites in Indiana.
Cities in Indiana
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
- Indiana University, Indianapolis
RecruitingPhase 1
Ages 18 to 69 · All sexes · Updated Sep 28, 2026 · NCT07241234A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
- Indiana University School of Medicine, Indianapolis
RecruitingPhase 3
Up to age 9 · All sexes · Updated Aug 28, 2026 · NCT06302348A Study of MZE782 in Adults With PKU
- Indiana University School of Medicine, Indianapolis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07694440Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
- Indiana University School of Medicine, Indianapolis
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Jun 17, 2026 · NCT07477691A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
- Indiana University School of Medicine, Indianapolis
RecruitingObservational study
All ages · All sexes · Updated Mar 25, 2026 · NCT05813678A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
- Riley Children's Hospital/ Indiana University Health, Indianapolis
RecruitingObservational study
All ages · All sexes · Updated Mar 24, 2026 · NCT06305234From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.